Replies to post #6189 on Hemispherx BioPharma (HEB)

[fourkids_9pets]

and HEB's *8k* FILED ~

http://xml.10kwizard.com/filing_raw.php?repo=tenk&ipage=7311695

--
4kids
all jmo

[fourkids_9pets]

now i know why the *activity* kicked in on 12/23
and noted in rt (real time) via this post in this venue

head fake or cleanup via the specialists
in advance of monday's data or something
else entirely .. amex *specialist* CINC
currently sitting on ask at .5299 .. hmmmmm :)

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=58086234

btw monday's data i was referring to pertained to the
*2 weeks in arrears* legal short data .. not to be confused
with the non legal kind or the daily reg sho data put out by
finra ..

=====

take notes

(c) The estimated fair value of the Liability related to the Warrants will be revalued at the end of each fiscal quarter from June 2009 through December 31, 2009.Due to the decreasing trading value of the Company's stock during this period, at December 31, 2009, the value of the Liability related to the remaining outstanding Warrants will be $3,162,000.The Company believes that the June to December 2009 year to date adjustments to record the change in fair value for the remaining Warrants' Liability will be $8,811,000, resulting in a related non-cash gain of $8,811,000.


The Company believes that the combined losses of approximately $4,256,000 for the exercise of Warrants and the estimated gain of $8,811,000 from the fair value adjustment of the Liability will result in a net non-cash gain of approximately $4,555,000 for the year-end 2009.The impact of this non-cash adjustment will be to reduce the 2009's year-end Net Loss from approximately $13,438,000 to $8,883,000 .

The estimated fair value of the Liability related to the Warrants will be revalued at the end of each fiscal quarter on March 31, 2010 , June 30, 2010 and September 30 , 2010.Due to the movement in the trading value of the Company's stock during these periods, the value of the Liability related to the remaining outstanding Warrants will be approximately $4,223,000 , $2,096,000 and $2,346,000 , respectively, for the fiscal quarters ended March 31, 2010 , June 30, 2010 and September 30 , 2010.The revaluation of the estimated fair value of the Liability for the nine months ended September 30, 2010 will be approximately $815,000 , resulting in a related non-cash gain of $815,000 .

The above disclosures concerning the related impact of the anticipated restatement are estimations only, subject to the Company's finalization of the restatement and may change.

None of the above issues from this non-cash adjustment will actually affect the Company's revenues, operating expenses, liquidity or cash flows from past or future operations, except in the highly unlikely event the Company would be taken private.

--
at this point i'd vote for the co. going private
fed up with entities *entrusted* with fiduciary
and regulatory *responsibilities* leaking like a GD sieve
and entities so polluted as to be toxic

--
4kids
all jmo